Varian Introduces IntelliBlate in Europe, Advancing an Integrated Microwave Ablation Solution for Image-Guided Cancer Therapy
Designed to provide clinicians with greater predictability, precision, and control, IntelliBlate serves as the cornerstone of a future-focused, integrated ecosystem for microwave ablation. This therapeutic device complements the Siemens Healthineers' suite of imaging and software solutions including: myAblation Guide for planning and post-procedural confirmation software, myNeedle Laser guidance system that enhances placement with a CT scan, and ultrasound for assessment, placement, and monitoring during treatment. With the addition of IntelliBlate, the Varian and Siemens Healthineers' offerings allow clinicians to plan, place, treat, monitor, and confirm ablation therapy in one environment, simplifying workflow and supporting greater confidence in targeting and treatment.
IntelliBlate delivers the versatility to meet the unique clinical needs of each patient. It produces large, controlled spherical ablation zones for predictable treatment delivery. A novel feature, the Ximitry probe's thermocouples provide continuous temperature monitoring inside and outside the ablation zone, allowing clinicians to observe real-time temperature changes and make informed decisions.
The system provides two generators in one system making it compact and portable. The intuitive interface with fast set up and pre-programmed ablation zone settings makes the IntelliBlate a streamlined solution that helps reduce procedural barriers.
Following receipt of its U.S. FDA market clearance in 2024, IntelliBlate enters the European market at a time of growing clinical evidence around thermal ablation. The COLLISION trial 1, a large international phase 3 study, published in The Lancet Oncology, demonstrated that thermal ablation can be as effective as the gold standard, surgical resection alone, in treating small-size colorectal liver metastases (CRLM) while resulting in significantly fewer complications, comparable overall survival, and shorter hospital stays for patients.
'The results of the COLLISION trial mark a milestone in how we think about ablation,' said Franck Facchini, President of Interventional Solutions at Varian. 'We have reached the point where the clinical evidence unrefutably supports the use of thermal ablation as a first-line treatment option, and not just an option for patients who cannot undergo surgery. IntelliBlate was designed to meet this shift in care, combining precision with intelligent software and imaging in a solution that fits seamlessly into modern cancer care workflows.'
IntelliBlate will be introduced to the European clinical community in September at CIRSE 2025, the leading European Congress for interventional radiology in which Varian and Siemens Healthineers will offer hands-on demonstrations and educational sessions to support training, best practice and early clinical adoption.
IntelliBlate represents a more targeted, less invasive approach to cancer care, offering new options to clinicians and new hope to patients. It reflects Varian's commitment and investment to becoming a leading innovator in interventional solutions and envisioning a world without the fear of cancer. Varian's journey with Siemens Healthineers is just getting started; together, we are committed to the continued development of a smart, integrated approach that connects innovative therapy technologies and image-guided solutions.
© 2025 VARIAN MEDICAL SYSTEMS, INC. All trademarks are the property of their respective owners.
About Varian
At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 75 years, Varian has developed, built, and delivered innovative technologies and solutions that help care providers around the globe treat millions of patients each year. Today, as a Siemens Healthineers company, we support every step of the cancer care journey – from screening to survivorship. From advanced imaging and radiation therapy to comprehensive software and services, to interventional radiology, we are harnessing the power of our perspective while also pursuing clinical research to create a more efficient, and more personalized care pathway. Because, for cancer patients everywhere, their fight is our fight. For more information, visit http://www.varian.com.
QR700024726
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Graham, Blumenthal hail Trump's new Russia sanctions plan
Sens. Lindsey Graham (R-S.C.) and Richard Blumenthal (D-Conn.), who have been pushing for a Russia sanctions bill, on Monday hailed President Trump's threat of tougher sanctions on Moscow if Russian President Vladimir Putin doesn't wind down his country's attacks on Ukraine in the coming weeks. 'It is long overdue for the financial backers of Russia's atrocities in Ukraine to pay a price for buying cheap energy products and marking it up in order to benefit their economies. The days of doing this without consequences are coming to an end,' the senators said in a joint statement after Trump's remarks at the White House. 'The combination of more American-made, European-purchased weapons for Ukraine and tariffs on the financial backers of Putin's brutal war has changed the game.' Trump warned Russia on Monday that he's prepared to levy 100 percent secondary economic sanctions in 50 days, which would target other nations that do business with Russia. 'We're very, very unhappy with [Russia], and we're going to be doing very severe tariffs if we don't have a deal in about 50 days,' Trump said during a meeting with NATO Secretary-General Mark Rutte. 'We are very unhappy — I am — with Russia.' Graham and Blumenthal have a Russia sanctions bill with more than 80 co-sponsors in the Senate. The latest version would empower Trump to impose a 500 percent tariff on imports from any nation that purchases Russian uranium, gas or oil. 'Finally, as President Trump indicated, we will join our colleagues in continuing to work with the White House on our bipartisan Russia sanctions legislation that would implement up to 500 percent tariffs on countries that buy Russian oil and gas, and do not help Ukraine,' the senators said Monday. 'The congressional legislation authorizing tariffs and sanctions would truly be a sledgehammer for President Trump to end this war, and it will allow for maximum flexibility to achieve that end.' 'The benefit of our approach is that it blends congressional authorization of tariffs and sanctions with flexibility for presidential implementation, making it rock solid legally and politically,' they added. Trump, who has previously praised Putin, has been expressing increasing frustration with Russia's leader over what he described as disingenuous efforts to end the conflict with Ukraine. Trump campaigned on brokering a peace deal between the warring rivals last year. He reiterated that position during Monday's White House meeting. 'I go home and tell the first lady, 'I spoke with Vladimir today. We had a wonderful conversation.' She says, 'Oh really? Another [Ukrainian] city was just hit,'' Trump recalled. 'We're very, very unhappy with them and we're going to be doing very severe tariffs if we don't have a deal in 50 days,' he said. 'Tariffs at about 100 percent.' The White House later clarified that Trump meant 'secondary sanctions' and not tariffs. 'You can do tariffs or you can do sanctions, those are both tools in his toolbox,' Commerce Secretary Howard Lutnick told reporters after the president's remarks. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
26 minutes ago
- Yahoo
Which countries could Trump hit with 100% tariffs over ties with Russia?
More than a dozen countries from Asia to the Middle East and South America are potentially in President Trump's crosshairs if he goes ahead with his threat to impose 100% tariffs on goods exported to the United States over their economic ties with Russia. "We're going to be doing very severe tariffs if we don't have a deal in 50 days, tariffs at about 100%," Mr. Trump said Monday at the White House, laying out a new ultimatum and deadline for Russia to agree to a ceasefire to end its war in Ukraine. The levies, he said, would be applied as "secondary tariffs" — not targeting Russia directly, but designed to increase Moscow's economic pain by pressuring its trade partners to stop buying or selling products in the energy, agriculture and weapons sectors with Russia. China and India became the world's first and second biggest importers of Russian oil in 2023 after Western sanctions were imposed against Moscow in response to its invasion of Ukraine in 2022. The top post had previously been held by the 27-nation European Union. China and India, Asia's two biggest economies, now collectively import an estimated 85% to 90% of the seaborne crude oil sold by Russia's state-managed energy companies, which make up the bulk of its total exports. After launching its full-scale invasion in February 2022, the Kremlin renegotiated prices with its trade partners, offering steep discounts on Russian oil compared to U.S. and European crude. NATO member Turkey is another major importer of Russian oil and natural gas. In the Middle East, the United Arab Emirates — while not a major energy importer itself — serves as a financial hub for the international trade in Russian oil. Dubai is also a safe haven for Russian capital and oligarchs. In South America, agricultural powerhouse Brazil is the biggest purchaser of Russian fertilizer products, crucial to supporting its soybean, sugar and coffee exports. Vietnam and Thailand, both of which try to maintain diplomatic non-alignment in the Russia-Ukraine war — leaving them stuck in a delicate balancing act between their Eastern and Western trade partners — do have oil, natural gas, defense and tourism interests with Russia. Senior Russian officials were quick to downplay the threat of secondary sanctions against its trading partners, and to reject Mr. Trump's ultimatum as "unacceptable." The president's remarks didn't cause any immediately apparent unease for Russian investors, either, possibly as Mr. Trump left a window of 50 days for some new agreement to take shape, and as he has a recent history of stepping back from previous tariff threats. After Mr. Trump warned of the possible 100% secondary tariffs, Russia's stock market rose 2.7%, and the value of the Russian rouble actually strengthened relative to the dollar. Trump pushes senators to make $9.4 trillion in spending cuts Congressman scolds protester at college antisemitism hearing: "Shut up and get out of here" Mike Waltz questioned about Signal chat scandal during confirmation hearing
Yahoo
32 minutes ago
- Yahoo
Analysis-Ferrero poised to revive WK Kellogg sales for health-conscious Americans
By Savyata Mishra (Reuters) -Nutella spread maker Ferrero, armed with experience in health-regulated European markets and a track record of revamping struggling brands like Keebler cookies, has a good chance of reviving WK Kellogg's legacy cereal brands with its $3.1 billion take-private deal announced last week. Ferrero, which makes sugary treats like Kinder chocolate eggs, Ferrero Rocher, and Tic Tac, has pursued an aggressive global expansion to boost revenue and diversify its portfolio beyond sweets into snacks, baked goods, and now breakfast cereals. Under Chairman Giovanni Ferrero, the company has invested heavily in product innovation, reformulation and packaging redesign to turn around some challenged brands it previously acquired such as Keebler from Kellogg. Meanwhile, demand has fallen for products made by WK Kellogg, whose cereals include Special K, Corn Flakes and sweetened offerings such as Froot Loops, Honey Smacks and Frosted Flakes. Consumers have traded down from its pricier cereals even as Kellogg has come under scrutiny for using artificial food dyes. "Ferrero's creativity can help jump-start sales in a sleepy (albeit higher margin) category," said Hank Cardello, executive-in-residence at the Business for Impact center at Georgetown's McDonough School of Business. Ferrero's expertise in cookies and confectionery could help create distinct new versions of cereal products, he added. Ferrero could reinvigorate WK Kellogg's portfolio which also contains healthier options such as Special K and Raisin Bran, touted for their high fiber content, as well as nutrient-rich cereals, granola and waffles under its Kashi brand. "I expect that (Ferrero) will preserve Kellogg brand recognition without too much dilution while also marketing a healthier and more consumer-friendly and appealing product line," Amrita Bhasin, CEO of logistics food and beverage company Sotira, said. In 2018, Ferrero bought Nestle's confectionery business for $2.8 billion, adding brands such as candy bars Butterfinger, Baby Ruth, and 100 Grand to its portfolio. In just a few years, Ferrero relaunched Butterfinger with higher-quality ingredients including peanuts, cocoa and milk and revamped packaging. The steps helped grow demand for the salted caramel bars. In 2019, Ferrero made a $1.3 billion acquisition of Kellogg's cookies, snacks and ice cream business. The Italian company revitalized these products by investing in new packaging and more marketing. In 2023, it also bought Fresystem Group and used the acquisition to grow its frozen food business and launch Nutella muffins and other baked goods. Ferrero declined to comment on the strategy for WK Kellogg. In April, WK Kellogg said it was reformulating its cereals served in schools to not include artificial dyes. Other packaged food makers such as PepsiCo, Kraft Heinz and Hershey have also started working to remove synthetic food dyes from their products, under pressure from U.S. Health Secretary Robert F. Kennedy Jr.'s Make America Healthy Again, or MAHA campaign. Analysts and industry experts noted that Ferrero has spent decades dealing with European regulators that have pushed back on additives, coloring and sugar. This could give the confectionery giant an edge dealing with Kennedy's MAHA campaign, they said. "Ferrero has been a pioneer in marketing smaller portions, which would fit in well with MAHA," Cardello said. For instance, as a founding member of the Always a Treat initiative in 2017, Ferrero committed to ensuring that half of its single-serve packs contain 200 calories or less to help consumers manage their sugar intake. As a private family-owned company, Ferrero is insulated from the pressures of quarterly earnings, giving it more flexibility to invest in long-term brand building and product innovation. Analysts said this could be critical in reshaping WK Kellogg's product lineup over the next few years. Still, MAHA could boost costs for Ferrero as it makes its expansion push in North America. "Ferrero will have to grapple with MAHA requirements across the company, not just in cereal, since much of its business is based on candy and sugary snack foods," said Sky Canaves, an analyst with market research firm Emarketer. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
